Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | HALO | NUVL | ||
| Company | Crispr Therapeutics Ag | Halozyme Therapeutic | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 56.70 | 40.67 | 73.48 | ||
| High | 58.38 | 40.74 | 74.65 | ||
| Low | 55.57 | 39.79 | 70.13 | ||
| Last | 55.89 | 39.91 | 70.35 | ||
| Change | +0.82 | +0.09 | -2.14 | ||
| % Change | +1.49% | +0.23% | -2.95% | ||
| Volume | 1,424,084 | 902,785 | 346,463 | ||
| 20-Day Average Volume | 1,295,359 | 845,584 | 594,183 | ||
| Previous Close | 55.07 | 39.82 | 72.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.30 | 38.93 | 67.08 | ||
| 20-Day Raw Stochastic | 25.26% | 60.14% | 66.55% | ||
| 20-Day Relative Strength | 38.26% | 54.10% | 48.18% | ||
| Weighted Alpha | -18.09 | +23.22 | +46.33 | ||
| Today's Opinion | 40% Sell | 40% Buy | 8% Buy | ||
| Previous Opinion | 40% Sell | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 04/26/24 | +3.47% since 04/26/24 | +5.22% since 04/26/24 | ||
| Low | 52.73 on 04/30/24 | 37.97 on 04/30/24 | 66.44 on 04/29/24 | ||
| High | 58.38 on 05/03/24 | 40.74 on 05/03/24 | 74.65 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -13.48% since 04/03/24 | -0.80% since 04/03/24 | -4.93% since 04/03/24 | ||
| Low | 52.73 on 04/30/24 | 37.73 on 04/19/24 | 61.79 on 04/19/24 | ||
| High | 67.25 on 04/04/24 | 41.50 on 04/05/24 | 75.22 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -13.68% since 02/02/24 | +18.50% since 02/02/24 | -8.03% since 02/02/24 | ||
| Low | 52.73 on 04/30/24 | 33.15 on 02/05/24 | 61.79 on 04/19/24 | ||
| High | 91.10 on 02/22/24 | 42.64 on 03/13/24 | 89.39 on 03/13/24 | ||
| 6-Month | |||||
| %Chg | +9.61% since 11/03/23 | +12.17% since 11/03/23 | +24.84% since 11/03/23 | ||
| Low | 48.55 on 11/13/23 | 33.15 on 02/05/24 | 55.25 on 11/06/23 | ||
| High | 91.10 on 02/22/24 | 42.82 on 12/14/23 | 89.39 on 03/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,674,507 | 5,059,291 | 4,644,290 | ||
| Shares Outstanding, K | 84,883 | 127,054 | 64,068 | ||
| Annual Sales | 371,210,000 | 829,250,000 | 0 | ||
| Annual Net Income | -153,610,000 | 281,590,000 | -126,220,000 | ||
| Last Quarter Sales | 201,210,000 | 230,040,000 | 0 | ||
| Last Quarter Net Income | 89,350,000 | 85,390,000 | -38,290,000 | ||
| 60-Month Beta | 1.80 | 1.26 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | 0.82 on 02/20/24 | -0.62 on 02/27/24 | ||
| Latest Earnings Date | 05/13/24 | 05/07/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.41 | 0.00 | ||